ENTITY

Ergomed (ERGO LN)

18
Analysis
Health Care • United Kingdom
Ergomed provides specialized services to the pharmaceutical and biotechnology industries, focusing on clinical development, trial management, and pharmacovigilance. The company operates through two segments: Clinical Research Services (CRO) and Pharmacovigilance (PV), offering solutions for all phases of clinical trials and post-approval drug safety. Ergomed was founded in 1997 and is headquartered in Guildford, United Kingdom.
more
bullish•Ergomed
•09 Aug 2026 11:48

Primer: Ergomed (ERGO LN) - Aug 2026

Privately Held with Strong Backing: Following its acquisition by private equity firm Permira in November 2023 for approximately £703.1 million,...

Logo
92 Views
Share
x